PMA device
SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra C Adaptive Prestent
Edwards Lifesciences, LLC · Pulmonary Valve Prosthesis Percutaneously Delivered (NPV, ) · First FDA decision Aug 31, 2020, newest Oct 27, 2026Congenital heart disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
10
PMA pathway
Device trials
51
Naming "SAPIEN 3"
MAUDE reports
24,850
Brand "SAPIEN 3", since 2015
PubMed studies
1,126
Mentioning "SAPIEN 3"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra C Adaptive Prestent
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 10 decisions filed under this name.
P200015-S077 · Decided Oct 27, 2026 · 180 days after receipt · Normal 180 Day Track
Device type: Pulmonary valve prosthesis percutaneously delivered (NPV) · Cardiology
- Edwards SAPIEN 3 Pulmonic Delivery System: 9630PL29PMA supplement
P200015-S069 · Decided Jul 17, 2026 · 345 days after receipt · Normal 180 Day Track No User Fee
Device type: Pulmonary valve prosthesis percutaneously delivered (NPV) · Cardiology
P200015-S068 · Decided Jan 28, 2026 · 180 days after receipt · Normal 180 Day Track
Device type: Pulmonary valve prosthesis percutaneously delivered (NPV) · Cardiology
3 more FDA decisions with a free account
Older decisions: P200015-S021, P200015-S011, P200015-S009, P200015
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SAPIEN 3", any status and sponsor, newest update first.
- ALTERRA: SAPIEN 3 THV With the Alterra Adaptive PrestentActive, not recruiting
Edwards LifesciencesPublic (EW)
NCT03130777 · 86 participants · Start Aug 22, 2017 · Primary completion Jul 14, 2022
Device: Edwards Alterra Adaptive Prestent with SAPIEN 3 THV · For: Pulmonary Disease; Transcatheter Pulmonary Valve Replacement (TPVR); Tetralogy of Fallot and 2 more
Sites: Los Angeles, California; San Francisco, California; Aurora, Colorado · 14 sites in all
- Balloon vs. Self Expanding Transcatheter Valve for Degenerated BioprosthesisPivotal-lookingRecruiting
Erasmus Medical CenterAcademic, hospital or other
NCT04843072 · 600 participants (planned) · Start May 1, 2021 · Primary completion Jun 1, 2028
Device: EVOLUT R/PRO/PRO+/FX bioprosthesis; Edwards Sapien S3/Ultra bioprosthesis and 1 more · For: Valve Heart Disease
Sites: Los Angeles, California; Vienna, Austria; Vancouver, Canada · 14 sites in all
- ALTERRA Post-Approval StudyActive, not recruiting
Edwards LifesciencesPublic (EW)
NCT05378386 · 150 participants · Start May 12, 2022 · Primary completion Sep 25, 2025
Device: Edwards Alterra Adaptive Prestent with SAPIEN 3 Transcatheter Pulmonary Valve System · For: Pulmonary Valve Insufficiency; Complex Congenital Heart Defect; Tetralogy of Fallot and 2 more
Sites: Birmingham, Alabama; Little Rock, Arkansas; Los Angeles, California · 24 sites in all
48 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SAPIEN 3", and for the whole product code for context.
This brand
24,850 reports: 1,170 malfunction, 21,270 injury, 2,409 death
Whole product code NPV
2,196 reports: 375 malfunction, 1,749 injury, 72 death
Newest reports for this brand
2015691-2026-19854 · Received Oct 30, 2026 · Event dated Sep 30, 2026
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Calcified
Patient problem as coded: Chest Pain; Dyspnea
2015691-2026-19877 · Received Oct 30, 2026 · Event dated Sep 29, 2026
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Insufficient Information
2015691-2026-19833 · Received Oct 29, 2026
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SAPIEN 3"[tiab]. The summary above synthesizes these.
- SAPIEN 3 Ultra Resilia: Critical Reflections on Real-World Performance.
Amat-Santos IJ, García-Gómez M · JACC Cardiovasc Interv · 2024Editorial, Comment
- Outcomes of transcatheter pulmonary SAPIEN 3 valve implantation: an international registry.
Hascoët S, Bentham JR, Giugno L, et al. · Eur Heart J · 2024Observational Study, Research Support, Non-U.S. Gov't
- Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients.
Madhavan MV, Kodali SK, Thourani VH, et al. · J Am Coll Cardiol · 2023Randomized Controlled Trial
- SAPIEN 3 in type 0 bicuspid aortic valves: Promising early results.
Alperi A, Avanzas P · Int J Cardiol · 2025Editorial
- Sapien 3: A Triple Threat to Aortic Stenosis.
Kar S, Sharma R · JACC Cardiovasc Interv · 2015Editorial, Comment
- Valve Wars: Sapien vs Evolut Transcatheter Valves, Whac-a-Mole Edition.
Jacquemyn X, Sultan I · Can J Cardiol · 2025Editorial
- SAPIEN 3 Ultra Transcatheter Aortic Valve Device: Two Sides of the Moon.
Barbanti M, Costa G · JACC Cardiovasc Interv · 2020Editorial, Comment
- ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation.
Pellegrini C, Rheude T, Renker M, et al. · EuroIntervention · 2023
- [Retrieval of the Ruptured Balloon during Transcatheter Aortic Valve Replacement without Complications:Report of a Case].
Hayakawa M, Domoto S, Azuma T, et al. · Kyobu Geka · 2021Case Reports
- Glimpse Into the Hemodynamic Performance of Myval Series vs Sapien 3 Ultra Resilia.
Tobe A, Onuma Y, Soliman O, et al. · Struct Heart · 2025
- Multicenter Pivotal Study of the Alterra Adaptive Prestent for the Treatment of Pulmonary Regurgitation.
Dimas VV, Babaliaros V, Kim D, et al. · JACC Cardiovasc Interv · 2024Multicenter Study, Clinical Trial
- Use of the SAPIEN 3 Transcatheter Heart Valve in High-Risk Scenarios.
Nascimbene A, McAlister C, Yo D, et al. · Tex Heart Inst J · 2022
Other devices of this type
Also filed under product code NPV.
- Harmony TPV SystemMedtronic, Inc. · PMA 2026
- Edwards Commander Delivery SystemEdwards Lifesciences, LLC · PMA 2023
- Melody Transcatheter Pulmonary ValveMedtronic, Inc. · PMA 2017
- Edwards Alterra Adaptive Prestent SystemEdwards Lifesciences, LLC · PMA 2022
- Harmony Transcatheter Pulmonary ValveMedtronic, Inc. · PMA 2022
- 9600CR CrimperEdwards Lifesciences, LLC · PMA 2022
- Melody TPV SystemMedtronic, Inc. · PMA 2019
- Ensemble II Transcatheter Valve Delivery SystemMedtronic, Inc. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.